title: Circulating dendritic cell subsets in psoriatic patients before and after biologic therapy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Prignano
authors.forename: Federica
authors.initials: F
authors.lastname: Ricceri
authors.forename: Matteo
authors.initials: M
authors.lastname: Beccatti
authors.forename: Paola
authors.initials: P
authors.lastname: Di Gennaro
authors.forename: Claudia
authors.initials: C
authors.lastname: Fiorillo
authors.forename: Torello
authors.initials: T
authors.lastname: Lotti
authors.forename: Niccolo
authors.initials: N
authors.lastname: Taddei
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D003713:Dendritic Cells / Q000187:drug effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab